Northern Capital Management (Wisconsin)’s Pfizer PFE Stock Holding History

Northern Capital Management (Wisconsin)’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-23,996	Closed	-$1M	–	169
2018 Q3	$1M	Sell	23,996 -15,378	-39%	-$592K	0.23%	118
2018 Q2	$1.35M	Sell	39,374 -1,555	-4%	-$53.1K	0.33%	105
2018 Q1	$1.38M	Buy	40,929 +1,423	+4%	+$48.9K	0.36%	101
2017 Q4	$1.36M	Buy	+39,506	New	+$1.35M	0.35%	105
2014 Q4	–	Sell	-52,657	Closed	-$1.48M	–	147
2014 Q3	$1.48M	Buy	52,657 +896	+2%	+$25.1K	0.75%	56
2014 Q2	$1.46M	Buy	51,761 +2,872	+6%	+$81.9K	0.72%	56
2014 Q1	$1.49M	Buy	48,889 +2,080	+4%	+$62K	0.74%	57
2013 Q4	$1.36M	Sell	46,809 -5,165	-10%	-$150K	0.71%	57
2013 Q3	$1.42M	Buy	51,974 +23,768	+84%	+$647K	0.83%	53
2013 Q2	$750K	Buy	+28,206	New	+$779K	0.47%	70

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Capital Management (Wisconsin)'s PFE Position: Q4 2018 in Review

Northern Capital Management (Wisconsin) sold out of Pfizer (PFE) in Q4 2018, closing a stake of 23,996 shares — an estimated $1M sold.

Northern Capital Management (Wisconsin) first reported a position in PFE in Q2 2013 and held it in 10 quarters. The position peaked at $1.49M in Q1 2014. 2,404 funds tracked by Wall St. Rank hold PFE as of Q4 2018.

Northern Capital Management (Wisconsin) reported no remaining Pfizer position as of Q4 2018 after selling out during the quarter.
Northern Capital Management (Wisconsin) sold 23,996 Pfizer shares in Q4 2018, an estimated $1M.
Northern Capital Management (Wisconsin) first reported a position in Pfizer in Q2 2013 and held it in 10 quarters.
Northern Capital Management (Wisconsin)'s Pfizer position peaked at $1.49M in Q1 2014.
2,404 funds tracked by Wall St. Rank held Pfizer as of Q4 2018.

Based on Northern Capital Management (Wisconsin)'s 13F filing for Q4 2018, filed 1 Feb 2019.